Biodexa Pharmaceuticals’ prospectus covers the resale of up to 170,150 ordinary shares, represented by 3,403 American Depositary Shares, by selling shareholders. For investors, the structure identifies a Shareholder resale rather than an issuer-led offering, while the securities are listed on the Nasdaq Capital Market under BDRX.
Key Highlights
- Each ordinary share carries a nominal value of £0.000001.
- Biodexa Pharmaceuticals registered the resale of up to 170,150 ordinary shares.
- The ordinary shares are represented by 3,403 American Depositary Shares.
Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) has registered the resale of up to 170,150 ordinary shares by selling shareholders. The ordinary shares are represented by 3,403 American Depositary Shares, making the transaction a shareholder resale rather than an issuer-led sale. The prospectus supplement is dated September 11, 2026.
170,150 Shares For Resale
The securities covered by the resale registration are ordinary shares with a nominal value of £0.000001 each. The prospectus supplement amends and supplements a prospectus dated March 30, 2026, and applies to the aggregate amount identified for resale by the selling shareholders. The registered securities are held within the shareholder resale structure.
3,403 ADS Representation
The 170,150 ordinary shares are represented by 3,403 American Depositary Shares. The transaction therefore covers both the underlying ordinary shares and their American Depositary Share representation.
Biodexa Pharmaceuticals’ securities remain identified for trading on the NASDAQ Capital Market under BDRX, while the registered sellers are the selling shareholders.
FAQs
Q: How many shares does the Biodexa resale offering cover?
A: The Biodexa resale prospectus covers up to 170,150 ordinary shares. Those ordinary shares are represented by 3,403 American Depositary Shares listed under BDRX.
Q: Who is selling the Biodexa Pharmaceuticals shares?
A: The selling shareholders are the sellers identified for the resale. Biodexa Pharmaceuticals is not identified as the selling party in the transaction structure.
Q: What does the BDRX resale registration mean for investors?
A: The registration concerns a shareholder resale of ordinary shares represented by American Depositary Shares. The securities trade on the NASDAQ Capital Market under BDRX.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.